Acasti Pharma Inc. (ACST)
NASDAQ: ACST
· Real-Time Price · USD
3.37
0.13 (4.01%)
At close: Oct 25, 2024, 10:00 PM
Acasti Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -9.57M | -13.64M | -11.61M | -11.45M | -12.85M | -38.77M | -40.27M | -41.93M | -42.43M | -17.25M | -17.14M | -11.22M | -9.82M | -11.56M | -11M | -18.13M |
Depreciation & Amortization | 7K | 7K | 5K | 5K | 11K | 18K | 27K | -36K | 124K | 116K | 106K | 167K | n/a | 1K | 1K | 376K |
Stock-Based Compensation | 730K | 802K | 995K | 1.07M | 913K | 1.01M | 1.12M | 1.43M | 1.81M | 2.1M | 2.12M | 1.65M | 1.34M | 892K | 408K | 695K |
Other Working Capital | -229.88K | 222K | 1.94M | 1.26M | -1.38M | -1.48M | -2.3M | -784.66K | 196.31K | -156.73K | -24.98K | -1.08M | n/a | 3.34M | 3.34M | 1.27M |
Other Non-Cash Items | -2.87M | -1.43M | -1.81M | 338.55K | 1.75M | 35.62M | 35.77M | 33.98M | 33.63M | -1.21M | -1.81M | -6.4M | -5.97M | -796K | 825K | 5.56M |
Deferred Income Tax | -3.2M | -3.03M | -2.67M | -2.27M | -1.83M | -9.81M | -9.88M | -9.59M | -9.54M | -671K | -397K | -242K | n/a | -3.24M | -3.24M | n/a |
Change in Working Capital | n/a | 203K | 2.3M | 1.63M | -1.3M | -1.63M | -2.17M | -574K | 181K | 860K | 212K | -3.52M | -2.79M | -4.38M | -5.71M | -5.3M |
Operating Cash Flow | -14.9M | -16.19M | -11.9M | -9.77M | -12.42M | -13.57M | -15.4M | -16.73M | -15.91M | -15.73M | -16.59M | -19.26M | -17.23M | -15.85M | -15.48M | -13.55M |
Capital Expenditures | 1.00 | n/a | -22K | -22K | -22K | -8K | -7.77K | -9.77K | -16.77K | -8.77K | -9K | -7K | n/a | 69K | 69K | 36K |
Cash Acquisitions | -0.31 | n/a | 935.73 | 111.01K | 111.01K | 86.1K | 86.85K | -23.1K | -23.1K | -96.99 | 129.83 | n/a | n/a | -54K | -54K | n/a |
Purchase of Investments | -15K | -15K | -6.62M | -6.62M | -6.61M | -1.54M | 14K | 16K | n/a | -5.09M | -13.41M | -26.64M | -34.93M | -43.27M | -31.32M | -18.11M |
Sales Maturities Of Investments | 15K | 15K | 6.57M | 6.57M | 6.57M | 5M | 18.18M | 18.09M | 31.37M | 26.46M | 27.15M | 43.31M | 31.41M | 31.32M | 17.44M | 1.4M |
Other Investing Acitivies | 1.31 | 88.1K | 89.07K | 89K | 89K | -4.99M | -18.18M | -18.18M | -1.1M | -31.04M | -31.18M | -44.4M | -61.48M | -36.38M | -24.42M | -11.25M |
Investing Cash Flow | n/a | n/a | -73.92K | 36.08K | 51.08K | -1.45M | 101K | -105K | 13.15M | 8.17M | 13.73M | 16.66M | -3.52M | -11.95M | -13.88M | -16.75M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 65.33K | 65.33K | 86.33K | 86.33K | 325K | 629K | 803K | 803K | 499K | 195K | n/a | n/a | 159K | 159K | 158K |
Financial Cash Flow | 14.03M | n/a | -4.3K | 7.35M | 7.35M | 7.3M | 7.36M | 105.75K | 300.75K | 296.34K | 304K | 195K | n/a | 34.68M | 54.42M | 57.86M |
Net Cash Flow | -5.11M | -11.73M | -11.84M | -2.24M | -4.87M | -7.7M | -7.93M | -16.74M | -2.46M | -6.77M | -2M | -2.6M | -20.6M | 6.47M | 25.38M | 28.85M |
Free Cash Flow | -14.9M | -16.19M | -11.92M | -9.8M | -12.44M | -13.58M | -15.41M | -16.74M | -15.93M | -15.74M | -16.6M | -19.27M | -17.23M | -15.78M | -15.41M | -13.52M |